Heart Function Recovery After Balloon Angioplasty for Lung Blood Clots
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how a minimally invasive procedure called balloon pulmonary angioplasty (BPA) helps patients with chronic blood clots in the lungs improve their heart function and overall recovery. Researchers will measure blood flow patterns in your arteries before and after the procedure to understand how well your heart recovers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have been diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH—a condition where old blood clots block lung arteries) and your doctors agree you are a candidate for balloon angioplasty
- You have undergone or will undergo a right heart catheterization test showing specific blood pressure patterns in your lungs
- Your CTEPH cannot be treated with surgery, or you had surgery before but symptoms returned
- You are not pregnant, do not have active infections or uncontrolled diseases, and do not have advanced kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how CTEPH (a type of high blood pressure in the lungs caused by blood clots) affects heart function differently in men and women. It uses heart ultrasounds and pressure measurements to see if recovery after surgery differs by sex.
This study uses special heart scans (CMR with 4D flow) to see how a procedure called BPA affects blood flow in the heart and lungs for people with a rare type of high blood pressure in the lungs (CTEPH). It may help doctors understand how well BPA works beyond just symptoms.
This study tests whether a special exercise program called pulmonary rehabilitation can improve quality of life and health in adults with pulmonary hypertension. You will likely do breathing and light aerobic exercises under supervision.
This trial compares what happens when people with chronic thromboembolic pulmonary hypertension (CTEPH) either stop or continue taking the medication riociguat after they have done well following a procedure called balloon pulmonary angioplasty. The goal is to learn whether it is safe and better to stop the medication or keep taking it.
This trial tests whether balloon angioplasty can improve breathing and exercise ability in people who still have symptoms and blood flow problems 3 months or more after a pulmonary embolism. It is for those who have completed a pulmonary rehabilitation program.
This trial tests whether a procedure called balloon pulmonary angioplasty is safe and effective for people with chronic thromboembolic disease in the lungs, especially when surgery isn’t an option. If you have CTEPH, it may help improve lung blood flow and symptoms.
Hear when a new CTEPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.